AMEX
ASX
CPH
DOH
EURONEXT
HEL
HKSE
JKT
JPX
LSE
MEX
NSE
OSE
SHH
SIX
STO
TSX
XETRA
Russian
LithuanianLive Chart Being Loaded With Signals
Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products...
| Stats | |
|---|---|
| Current Price | KRW10 940 |
| Today's Volume | 9 405T |
| Average Volume | 254 319T |
| Market Cap | 167.94B |
| EPS | KRW 0 |
| P/E | 0 |
| ATR14 | KRW 15.70 (0.14%) |
Jeil Pharma Holdings Inc
Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.